Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.

BACKGROUND & AIMS Liver fibrogenesis is sustained by myofibroblast-like cells originating from hepatic stellate cells (HSC/MFs), portal fibroblasts or bone marrow-derived cells, including mesenchymal stem cells (MSCs). Herein, we investigated the mechanistic role of intracellular generation of reactive oxygen species (ROS) and redox-sensitive signal transduction pathways in mediating chemotaxis, a critical profibrogenic response for human HSC/MFs and for MSC potentially engrafting chronically injured liver. METHODS Intracellular generation of ROS and signal transduction pathways were evaluated by integrating morphological and molecular biology techniques. Chemokinesis and chemotaxis were evaluated by wound healing assay and modified Boyden's chamber assay, respectively. Additional in vivo evidence was obtained in human specimens from HCV-related cirrhosis. RESULTS Human MSCs and HSC/MFs migrate in response to a panel of polypeptide chemoattractants and extracellularly generated superoxide anion. All polypeptides induced a NADPH-oxidase-dependent intracellular rise in ROS, resulting in activation of ERK1/2 and JNK1/2. Moreover, menadione or 2,3-dimethoxy-1,4-naphthoquinone, which generate intracellular superoxide anion or hydrogen peroxide, respectively, induced ERK1/2 and JNK1/2 activation and migration. JNK1 activation was predominant for migration as shown by specific silencing. Finally, activation of ERK1/2 and JNK1/2 was found in extracts obtained from HSC/MFs during the course of an oxidative stress-mediated model of liver injury and phosphorylated JNK1/2 isoforms were detected in α-smooth muscle actin-positive myofibroblasts lining fibrotic septa in human cirrhotic livers. CONCLUSIONS Intracellular generation of ROS, through activation of specific signaling pathways, is a critical event for directional migration of HSC/MFs and MSCs.

[1]  C. Heldin,et al.  c-Jun N-terminal Kinase Is Necessary for Platelet-derived Growth Factor-mediated Chemotaxis in Primary Fibroblasts* , 2006, Journal of Biological Chemistry.

[2]  F. Marra,et al.  Extracellular signal‐regulated kinase activation differentially regulates platelet‐derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat , 1999, Hepatology.

[3]  K. Iwaisako,et al.  c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. , 2009, Gastroenterology.

[4]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[5]  G. Bellomo,et al.  HNE interacts directly with JNK isoforms in human hepatic stellate cells. , 1998, The Journal of clinical investigation.

[6]  M. Karin,et al.  From death receptor to reactive oxygen species and c‐Jun N‐terminal protein kinase: the receptor‐interacting protein 1 odyssey , 2007, Immunological reviews.

[7]  Katsunori Yoshida,et al.  Transforming growth factor-β and platelet-derived growth factor signal via c-jun N-terminal kinase- dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury , 2005 .

[8]  S. Forbes,et al.  Hepatic fibrogenesis: from within and outwith. , 2008, Toxicology.

[9]  R. Schwabe,et al.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.

[10]  F. Marra,et al.  Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. , 2008, Molecular aspects of medicine.

[11]  M. Bogoyevitch,et al.  The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). , 2001, The international journal of biochemistry & cell biology.

[12]  Katsunori Yoshida,et al.  Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. , 2005, The American journal of pathology.

[13]  F. Marra,et al.  Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans , 2005, Gut.

[14]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[15]  L. Mazzini,et al.  Bone Marrow Mesenchymal Stem Cells from Healthy Donors and Sporadic Amyotrophic Lateral Sclerosis Patients , 2008, Cell transplantation.

[16]  M. Karin,et al.  The control of cell motility and epithelial morphogenesis by Jun kinases. , 2004, Trends in cell biology.

[17]  A. Cederbaum Cytochrome P450 2E1‐dependent oxidant stress and upregulation of anti‐oxidant defense in liver cells , 2006, Journal of gastroenterology and hepatology.

[18]  D. Brenner,et al.  NADPH oxidase in the liver: defensive, offensive, or fibrogenic? , 2006, Gastroenterology.

[19]  F. Marra,et al.  Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells , 2005, Gut.

[20]  A. Vercelli,et al.  Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. , 2007, Journal of hepatology.

[21]  S. Milani,et al.  Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.

[22]  D. Brenner,et al.  Mechanisms of Fibrogenesis , 2008, Experimental biology and medicine.

[23]  R. Schwabe,et al.  Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. , 2010, Gastroenterology.

[24]  A. Gentilini,et al.  4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. , 2004, Journal of hepatology.

[25]  F. Bozzo,et al.  Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. , 2008, Carcinogenesis.

[26]  S. Milani,et al.  Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism , 2005, Hepatology.

[27]  F. Marra,et al.  Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. , 2007, The American journal of pathology.

[28]  E. Novo,et al.  Redox mechanisms in hepatic chronic wound healing and fibrogenesis , 2008, Fibrogenesis & tissue repair.

[29]  Roger G. Chui,et al.  c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. , 2005, Blood.

[30]  L. Gesualdo,et al.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.

[31]  E. Zamara,et al.  Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential , 2007, Gut.

[32]  A. Diehl,et al.  Epithelial‐to‐mesenchymal transitions in the liver , 2009, Hepatology.